The laboratory, “Biontech”, announced, on Monday, that it will deliver up to 75 million additional doses of its vaccine to the European Union in the second quarter of the year, in order to accelerate its provision.
The financial director of the laboratory, Sherk Potting, told AFP that the two partners, Pfizer – Biontech, intend to “increase deliveries from February 15, and provide the number of doses they committed to providing during the first quarter, up to 75 million additional doses.” The European Union during the second quarter “within the framework of the current contracts.
Potting added, “We have returned to the basic delivery plan,” after a slowdown in delivery due to modifications in the production chain at the Belgian factory, “Poor”, referring to “talks with other partners to sign new agreements,” without additional details.
The announcement coincided with a meeting scheduled for Monday between German officials and several pharmaceutical groups, in an attempt to revive the stalled vaccination campaign in Germany, similar to many European Union countries.
The European Union had requested a total of 600 million doses of the group vaccine, which is commercially called “Commernate”.
And the announcement of a temporary delay in the deliveries, raised the dismay of several European governments in mid-January, before the controversy that took place over the “AstraZeneca” vaccine and the reduction of the number of announced doses.
The English-Swedish laboratory, which will provide 40 million doses, will begin delivering the vaccine “initially in the second week of February,” according to a European source.
The President of the European Commission, Ursula von der Leyen, said that February and March would be a “difficult stage” in terms of vaccination, and acknowledged that the performance of the European Union in terms of vaccination is different from that recorded in Britain in particular.
And announced, “Pfizer – Biontech” on January 11, that they are able to produce billions of doses of their vaccine thanks to a new plant in Marburg in Germany, which will begin work during the current month.
This new goal takes into account the possibility of dividing one vial into six, not five doses, as well as a wider network of production sites that includes other companies such as Sanofi.
A Reuters statistics showed, on Monday, that more than 102.97 million people were infected with the emerging Corona virus worldwide, while the total number of deaths resulting from the virus reached two million 226 thousand and 771 people.
And HIV infections have been recorded in more than 210 countries and regions since the first cases were discovered in China in December 2019, according to data from health ministries and government officials.